Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > SCD interview!
View:
Post by Ciao on Aug 04, 2022 2:24pm

SCD interview!

Surprisingly Paul is a shareholder now and it was also a surprise to see this interview.

Comment by ZoranSto on Aug 04, 2022 4:10pm
Great find...thanks for sharing. Hoping that this will now get into the eyes of some new investors.
Comment by prophetoffactz on Aug 04, 2022 4:47pm
I had informed Paul about CZO and that Ronnie Miller had joined recently. I said that CZO has a profitable base business with major clients and that it is undervalued on this basis alone. I said that it had a number of catalysts before it. It is good to see that Paul is now not only a shareholder but an excited shareholder and that he has now done an interview.
Comment by prophetoffactz on Aug 04, 2022 6:23pm
It usually takes 90 days for Health Canada to give the green light for the avenanthramide clinical trial. We are simply waiting. Gilles appears positive based on conversations. Hopes it is a Phase I into a Phase IIa approved study that helps test efficacy. Phase I hoped to be initiated in Q4. University of Alberta bioavailability study expected in September. This could lead to a licensing deal ...more  
Comment by prophetoffactz on Aug 04, 2022 6:39pm
This post has been removed in accordance with Community Policy
Comment by prophetoffactz on Aug 04, 2022 6:40pm
This post has been removed in accordance with Community Policy
Comment by Minty_33 on Aug 04, 2022 9:34pm
"Juvente could have a cannabis cream for pain management by the end of the year." Could, possibly.....shut the fact up Juvente is the joke of the cosmetic world. on second thought, I take that back....,nobody knows them thanks to their marketing mind menopause.  They have a gold mine but instead of using bulldozers, dynamite and drills, they're using sculpting tools .  ...more  
Comment by lscfa on Aug 05, 2022 8:46am
The BG pill failed, should have been in liquid form. So why do they think an AVN pill won't fail too?
Comment by Ciao on Aug 05, 2022 9:37am
My 2 cents worth: They already have positive results where AV was used in cookies that reduced inflammation in a study of downhill runners. I would believe that the mechanism for removing ldl is quite different than reducing muscle inflammation wrt how the active ingredient works. Lastly lessons learned from BG pill must have been considered when moving towards this high purity pill.
Comment by ZoranSto on Aug 05, 2022 10:23am
Thanks, some good points. ALSO in the video he mentions a cash position of over $10,000,000 at the end of q1 (which generated 1.3 milloin in cash) we were at $8,781,752....SOOOO I think Q2 was very good
Comment by Ciao on Aug 05, 2022 10:33am
Yes, nice catch. Gilles said they would be generating approx. $1M of cash per quarter.
Comment by prophetoffactz on Aug 05, 2022 9:59am
Trials are often trial-and-error. The beta glucan trial may not been so much a failure as part of the trial-and-error process that ruled the pill form out. A liquid form would appear to do the trick based on other recent human results; but CZO has put that on the backburner for now given its other immediate pursuits. As Gilles said avenanthramide is CZO's flagship product and the reason he ...more  
Comment by lscfa on Aug 05, 2022 10:35am
co. finally talked about other potential cosmetic uses that could grow base biz revenues but interviewer failed to asked what is plant capacity and what is current utilization.   
Comment by prophetoffactz on Aug 07, 2022 6:13pm
An update from McMaster concerning fibrosis is hoped for this summer leading to a potential clinical trial. The bioavailability study results are expected in September leading to a potential licensing deal. Health Canada has 90 days to respond concerning the green light for the avenanthramide study and we are just waiting. The Angiogenesis Foundation study was said to be one year and that ends ...more  
Comment by ZoranSto on Aug 08, 2022 2:43pm
Good summary for up coming news. Seem to be getting some good volume today. I wonder if it is related to the you tube video....could be getting us more exposure. Just imagine what BNN segment would do :-)
Comment by Ciao on Aug 08, 2022 4:26pm
3rd highest volume in a year, alongside Q1 earnings release and Q2 should be out in a few weeks.  I would say at this time it's too premature for any BNN coverage. A commercial deal may be a good time to highlight the merits of this mircocap as it'll just be scratching the surface for the potential of the company. The SCD interview was a great idea to gain exposure to an audience of ...more  
Comment by Ciao on Aug 08, 2022 4:32pm
Surprisingly almost no trades on U.S. OTC till with 12 seconds left in the trading day, 20K changed hands.
Comment by ZoranSto on Aug 09, 2022 9:12am
Yes I saw that....I was wondering why there were ZERO trades all day then WHAM ...at the end of the day. I hope we have a good day today as well. Seems to be heavy accumulation these past few weeks. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities